Alliance
C4U enters into Non-Exclusive Sublicense Agreement with Nippon Gene
C4U and Nippon Gene have entered into a non-exclusive sublicense agreement granting Nippon Gene develop, manufacture and sell reagents utilizing CRISPR-Cas3 technology.
Alliance
C4U and Nippon Gene have entered into a non-exclusive sublicense agreement granting Nippon Gene develop, manufacture and sell reagents utilizing CRISPR-Cas3 technology.